Q3: 2026-04-30 Earnings Summary
EPS of $3.17 beats by $0.38
|
Revenue of
$60.94B
(11.05% Y/Y)
misses by $1.30B
Cardinal Health, Inc. (CAH) Q3 2026 Earnings Call April 30, 2026 8:30 AM EDT
Company Participants
Matt Sims - Vice President of Investor Relations
Jason Hollar - CEO & Director
Aaron Alt - Chief Financial Officer
Conference Call Participants
Michael Cherny - Leerink Partners LLC, Research Division
Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division
Erin Wilson Wright - Morgan Stanley, Research Division
Eric Percher - Nephron Research LLC
Allen Lutz - BofA Securities, Research Division
Glen Santangelo - Barclays Bank PLC, Research Division
George Hill - Deutsche Bank AG, Research Division
Stephen Baxter - Wells Fargo Securities, LLC, Research Division
Kevin Caliendo - UBS Investment Bank, Research Division
Inho Kim - TD Cowen, Research Division
Steven Valiquette - Mizuho Securities USA LLC, Research Division
Daniel Grosslight - Citigroup Inc., Research Division
Jack Slevin - Jefferies LLC, Research Division
Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division
Presentation
Operator
Hello, and welcome to the Third Quarter Fiscal Year 2026 Cardinal Health, Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is being recorded.
[Operator Instructions] I'd like to hand the call over to your host, Mr. Matt Sims, Vice President, Investor Relations, to begin today's conference. Please go ahead, sir.
Matt Sims
Vice President of Investor Relations
Good morning, and welcome to Cardinal Health's Third Quarter Fiscal '26 Earnings Conference Call, and thank you for joining us. With me today are Cardinal Health's CEO, Jason Hollar; and our CFO, Aaron Alt. You can find this morning's earnings press release and investor presentation on the Investor Relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。